IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 103 filers reported holding IMMUNOMEDICS INC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $233,000 | +36.3% | 26,400 | 0.0% | 0.01% | +42.9% |
Q1 2017 | $171,000 | +76.3% | 26,400 | 0.0% | 0.01% | +75.0% |
Q4 2016 | $97,000 | +12.8% | 26,400 | 0.0% | 0.00% | +33.3% |
Q3 2016 | $86,000 | +41.0% | 26,400 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $61,000 | -7.6% | 26,400 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $66,000 | -18.5% | 26,400 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $81,000 | +80.0% | 26,400 | 0.0% | 0.00% | +50.0% |
Q3 2015 | $45,000 | -55.4% | 26,400 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $101,000 | 0.0% | 26,400 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $101,000 | -20.5% | 26,400 | 0.0% | 0.00% | -20.0% |
Q4 2014 | $127,000 | +29.6% | 26,400 | 0.0% | 0.01% | +25.0% |
Q3 2014 | $98,000 | +2.1% | 26,400 | 0.0% | 0.00% | +33.3% |
Q2 2014 | $96,000 | -13.5% | 26,400 | 0.0% | 0.00% | -25.0% |
Q1 2014 | $111,000 | -8.3% | 26,400 | 0.0% | 0.00% | -20.0% |
Q4 2013 | $121,000 | -26.2% | 26,400 | 0.0% | 0.01% | -37.5% |
Q3 2013 | $164,000 | +13.9% | 26,400 | 0.0% | 0.01% | +14.3% |
Q2 2013 | $144,000 | – | 26,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |